AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
180 Life Sciences Surges 54% in After-Hours Trading After Raising $156 Million to Boost Ethereum Holdings
ByAinvest
Tuesday, Aug 12, 2025 8:46 pm ET1min read
180 Life Sciences Corp. ATNF shares surged 54% in after-hours trading after the biotech firm completed a $156 million private offering to boost its Ethereum reserves. The proceeds will be used to buy more ETH, expanding on its recently announced treasury strategy. Concerns have been raised about the potential collapse of Ethereum due to overleveraging practices.
180 Life Sciences Corp. (ATNF) shares surged 54% in after-hours trading on July 2, 2025, following the announcement of a $156 million private offering. The funds will be used to expand the company's Ethereum (ETH) holdings, further cementing its treasury strategy. The move comes as the biotech firm aims to capitalize on the growing demand for on-chain treasury management solutions.The private offering, completed on July 2, 2025, will provide 180 Life Sciences with an additional $156 million to bolster its ETH reserves. As of August 11, 2025, the company held a total of 82,186 ETH, valued at approximately $349 million [1]. This recent acquisition will further increase the company's ETH holdings, positioning it as a significant player in the Ethereum ecosystem.
The surge in ATNF shares can be attributed to the company's strategic move to expand its ETH reserves. The private offering will allow 180 Life Sciences to execute on its treasury strategy, which aims to generate yield through its external asset manager, Electric Capital. The company's plans to rebrand as ETHZilla Corporation and become a benchmark for on-chain treasury management among public companies have also contributed to investor optimism.
However, concerns have been raised about the potential collapse of Ethereum due to overleveraging practices. Despite these concerns, 180 Life Sciences remains committed to its treasury strategy, believing that the reserve of ETH will unlock cash flow for shareholders and deliver on its on-chain yield generation program.
The private offering is part of a broader strategy for 180 Life Sciences to evolve its business towards software-enabled gaming and entertainment. The company continues to maintain and accelerate the deployment and development of its gaming initiatives while also monetizing its existing biotech assets.
References:
[1] https://finance.yahoo.com/news/180-life-sciences-ethzilla-holds-120000891.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet